Clinical Trials GPS

Achieve Clinical Research recently opened up a new clinical trial, and they are looking to enroll individuals who are suffering from clinically relevant arthritis pain. Adults who are experiencing osteoarthritis symptoms of the knee could qualify.

The research team at Avail Clinical is looking for current or ex-smokers who have been clinically diagnosed with COPD. Those who qualify for this clinical study will be helping to evaluate a new remedy for this chronic respiratory disease.

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial.

The research team at Avail Clinical is conducting a clinical study to evaluate a new remedy for the common cold. Adults who are experiencing early cold symptoms, but are otherwise healthy, may qualify to participate.

The research team at Achieve Clinical is conducting a new clinical study in Birmingham, AL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age.

The research team at Avail Clinical is conducting new clinical studies in DeLand, FL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age.

Achieve is conducting a Phase III, randomized, placebo-controlled study to evaluate the safety and effectiveness of a new viscoelastic hydrogel, for the treatment of osteoarthritis (OA) of the knee.

Avail is conducting a Phase 2, randomized, placebo-controlled clinical research study to evaluate the efficacy, safety and pharmacokinetics of an experimental spray treatment for qualified participants with mild to moderate OA in the knee.

Achieve is conducting a multicenter, randomized, single-dose study assessing the pharmacodynamic parameters of an experimental combination therapy in patients with rheumatoid arthritis on stable methotrexate (MTX) treatment.

Avail is conducting a phase 1, open-label pharmacokinetic and pharmacodynamic study of a single dose of an experimental drug in subjects with hepatic impairment and in matched healthy volunteers.